Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Oct 29, 2026
TickeronGET DAILY SIGNALS
DaVita (DVA) vs. Kimco Realty (KIM): Momentum Play or Steady Income Generator?

DaVita (DVA) vs. Kimco Realty (KIM): Momentum Play or Steady Income Generator?

Key Takeaways

  • DVA (DaVita) and KIM (Kimco Realty) operate in unrelated sectors, yet both posted earnings beats and raised full-year guidance in their most recent reporting periods, supporting constructive sentiment across each name.
  • DVA has displayed stronger price momentum, with a sharp post-earnings surge and a year-to-date advance that has meaningfully outpaced the broader market, while KIM has delivered steadier, income-oriented performance.
  • KIM offers a defensive, dividend-focused profile with record portfolio occupancy, whereas DVA carries higher operational and regulatory sensitivity tied to dialysis reimbursement and payer mix.
  • Tickeron AI Verdict: DVA is the ticker of choice, favored for its stronger trend consistency, earnings catalysts, and relative momentum versus KIM.
  • For deeper coverage of company-specific developments and intraday activity, explore DVA Major News, DVA Today's Price Move, KIM Major News, and KIM Today's Price Move.
  • To see how automated strategies are navigating these and other names, explore Trending AI Robots.

Setting the Stage: A Growth-Income Comparison

Investors often face a classic choice between a high-growth healthcare provider and a steady real estate investment trust. The matchup between DVA and KIM highlights that tension. DVA, or DaVita, leads in kidney-care and dialysis services, while KIM, or Kimco Realty, focuses on grocery-anchored open-air shopping centers. Both companies recently delivered results that topped expectations and raised their full-year outlooks. Growth-oriented investors may lean toward DaVita’s momentum, whereas those seeking income might appreciate Kimco’s dividend and portfolio stability. This comparison looks at relative performance and positioning to help assess which approach fits the current market.

DaVita (DVA) Overview and Recent Results

DVA operates thousands of outpatient dialysis centers in the U.S. and abroad. In its latest quarter, the company reported adjusted EPS well above consensus estimates, with revenue up about 6% year over year thanks to solid treatment volumes and higher revenue per treatment. Management raised and tightened its full-year adjusted EPS and operating income guidance, pointing to better volume expectations and reduced patient-care costs. The stock reacted with a strong post-earnings move, and Deutsche Bank recently upgraded the shares to Buy with an increased price target. DaVita’s year-to-date performance has been solid, though it has eased from recent highs. Expansion of value-based care and its Integrated Kidney Care platform have helped sentiment, but reimbursement risks, payer-mix shifts, and competition stay important factors to monitor. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Kimco Realty (KIM) Overview and Recent Results

KIM is a REIT focused on neighborhood and community shopping centers, mostly grocery-anchored and located in suburban markets. Its most recent quarter showed funds from operations slightly ahead of consensus, with modest year-over-year revenue growth. The company reached record portfolio occupancy, accelerated same-property net operating income growth, and raised its full-year net income and FFO per share outlook. It also increased its quarterly dividend, reinforcing its income focus. Performance has been consistent rather than dramatic: shares are higher year to date but have lagged over the past three months. Key risks include e-commerce pressures, elevated debt, and interest-rate sensitivity around refinancing.

Head-to-Head Comparison

The main differences lie in business models and risk exposures. DVA is a growth-oriented healthcare operator reliant on treatment volumes, reimbursement rates, and value-based care expansion, which leaves it exposed to policy and payer-mix shifts. KIM is a capital-intensive REIT whose results depend on occupancy, rental spreads, and financing costs, making it more sensitive to interest rates and e-commerce trends. On momentum, DaVita has led with a stronger year-to-date gain and a clear earnings catalyst, while Kimco has provided steadier, dividend-supported returns. Kimco’s necessity-based retail focus and record occupancy give it a defensive edge that DaVita’s reimbursement concentration lacks. Valuation and income profiles also differ: Kimco offers a meaningful dividend yield, whereas DaVita emphasizes share repurchases and earnings growth. Market sentiment currently favors DaVita’s momentum, but Kimco appeals to investors prioritizing stability and income.

Tickeron AI Verdict

Based on trend consistency, relative momentum, and recent catalysts, Tickeron’s AI analysis points to DVA over KIM in the present environment. DaVita combines an earnings beat, raised guidance, an analyst upgrade, and stronger year-to-date trend characteristics that align with momentum signals. Kimco provides stability and income, yet its more modest price momentum and interest-rate sensitivity place it at a relative disadvantage in a trend-based view. This assessment reflects current positioning and could shift with new information.

Exploring Automated Trading Approaches

In my research process, I frequently review Tickeron’s Trending AI Robots to understand how automated systems are positioned across names like these. The page highlights a curated selection of bots suited to current conditions, allowing comparison of different strategies, risk levels, and performance records before deciding on any approach.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DVA, KIM

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


DVA sees MACD Histogram crosses below signal line

DVA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In 26 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DVA as a result. In 51 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.

DVA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DVA crossed bearishly below the 50-day moving average on November 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.

The 50-day moving average for DVA moved below the 200-day moving average on November 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

The Aroon Indicator for DVA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DVA's RSI Indicator exited the oversold zone, 18 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in 245 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

DVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. DVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.956) is normal, around the industry mean (204.532). P/E Ratio (15.431) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.436) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.153) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (2.688).

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -12%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was 0%. CHE experienced the highest price growth at 0%, while NIVF experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 13%. For the same stocks of the Industry, the average monthly volume growth was 102% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 49
Price Growth Rating: 59
SMR Rating: 66
Profit Risk Rating: 83
Seasonality Score: -4 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of integrated dialysis services for patients suffering from chronic kidney failure

Industry HospitalNursingManagement

Industry
Medical Or Nursing Services
Address
2000 16th Street
Phone
+1 720 631-2100
Employees
78000
Web
https://www.davita.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.